Changing the Face of Clinical Trials
Cutting-edge cancer treatments are the fruit of clinical research. Yet women and people of racial/ethnic minorities are consistently underrepresented in cancer clinical trials. What are the causes? What can we do to change that reality? Join us and Dr. Hilary Ma of MD Anderson to answer these questions and more!
Meet our Scientist
Dr. Hilary Ma
Dr. Ma is a medical oncologist at MD Anderson Cancer Center, Chief of Oncology at LBJ Hospital. His primary research interest is cancer health disparities.